Allele Biotechnology
- Biotech or pharma, therapeutic R&D
- Other R&D services
- CMO, CRO
Allele has developed a fully GMP-compliant method for producing iPSCs without viral or DNA contamination in our FDA-registered manufacturing facility. The mRNA approach also supports differentiation and gene editing; our pancreatic beta cells for diabetes, iPSC-derived hepatocytes for regenerative medicine for liver are for partnerships.
As a pioneer in mRNA composition, Allele designs tailored chemical structures of mRNA for various cell types and species. With over 15 years of nanobody development expertise, through proprietary stability enhancing and linker technologies, we offer a unique multi-target multi-valent platform for engaging, blocking, and modulating the half-life of drug candidates.
The Allele Reagent unit offers highly cited fluorescent proteins like mNeonGreen and mScarlet, and develops sensors for real-time calcium, voltage, and ion measurements. Delivered via mRNA in the mRNAExpress format, they enable high expression within hours, ideal for drug screening.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}